Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership17,143 shares
Latest Disclosed Value $ 61,372
ProShare Advisors LLC reports 15.42% decrease in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 17,143 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $48,258 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 20,268 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -15.42% during the quarter. The current value of the position is $41,829 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 17,143 -3,125 -15.42 61 -14.08 0.0001
2026-02-06 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 20,268 1,933 10.54 71 20.34 0.0001
2025-11-06 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 18,335 -2,887 -13.60 60 15.69 0.0001
2025-08-07 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 21,222 -271 -1.26 52 -64.34 0.0001
2025-05-08 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 21,493 -1,354 -5.93 143 -50.17 0.0003
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 22,847 5,035 28.27 287 -12.50 0.0007
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 17,812 3,802 27.14 329 8.97 0.0008
2024-08-13 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 14,010 -3,604 -20.46 302 -36.50 0.0008
2024-05-08 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 17,614 1,468 9.09 475 -1.86 0.0013
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 16,146 3,593 28.62 484 87.94 0.0015
2023-11-13 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 12,553 50 0.40 257 3.63 0.0008
2023-08-10 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 12,503 431 3.57 248 20.39 0.0007
2023-05-26 2023-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 12,072 -1,102 -8.36 207 -19.84 0.0006
2023-05-12 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 12,072 -1,102 207 0.0007
2023-02-02 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 13,174 2,793 26.90 258 53.89 0.0009
2022-11-07 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 10,381 338 3.37 167 20.14 0.0006
2022-08-01 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 10,043 -4,365 -30.30 139 -39.30 0.0005
2022-05-10 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 14,408 -3,675 -20.32 229 -41.88 0.0005
2022-02-08 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 18,083 -721 -3.83 394 -29.89 0.0008
2021-11-12 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 18,804 -2,892 -13.33 562 -41.52 0.0016
2021-08-13 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 21,696 3,353 18.28 961 18.06 0.0028
2021-05-14 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 18,343 2,275 14.16 814 -7.60 0.0026
2021-02-09 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 16,068 2,998 22.94 881 194.65 0.0033
2020-11-13 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 13,070 -373 -2.77 299 6.41 0.0014
2020-08-03 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 13,443 13,443 281 0.0015
2020-05-15 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -14,924 -100.00 0 -100.00
2020-02-12 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 14,924 -2,146 -12.57 340 70.85 0.0016
2019-11-12 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 17,070 -115 -0.67 199 -22.87 0.0011
2019-08-13 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 17,185 -133 -0.77 258 -15.13 0.0015
2019-05-15 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 17,318 1,614 10.28 304 30.47 0.0018
2019-02-14 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 15,704 15,704 233 0.0016
2017-02-13 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -18,685 -100.00 0 -100.00
2016-11-10 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 18,685 -3,122 -14.32 177 9.26 0.0025
2016-08-12 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 21,807 2,402 12.38 162 12.50 0.0021
2016-05-06 2016-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 19,405 -1,832 -8.63 144 -40.25 0.0020
2016-02-05 2015-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 21,237 21,237 241 0.0029
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.